Clinical Experience With Deferiprone Treatment for Friedreich Ataxia

Deferiprone in Friedreich ataxia: A 6-Month randomized controlled trial

(2014) Massimo Pandolfo et al.   ANNALS OF NEUROLOGY

Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial

(2013) J. Arpa et al.   ACTA NEUROLOGICA SCANDINAVICA

Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia

(2013) Sirena Soriano et al.   GENE

Deferiprone for the treatment of Friedreich's ataxia

(2013) Massimo Pandolfo et al.   JOURNAL OF NEUROCHEMISTRY

Friedreich Ataxia: Neuropathology Revised

(2013) Arnulf H. Koeppen et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Iron metabolism in the CNS: implications for neurodegenerative diseases

(2013) Tracey A. Rouault   NATURE REVIEWS NEUROSCIENCE

Regional siderosis: a new challenge for iron chelation therapy

(2013) Zvi Ioav Cabantchik et al.   Frontiers in Pharmacology

Chelating Agents for the Treatment of Systemic Iron Overload

(2012) Y. Ma et al.   CURRENT MEDICINAL CHEMISTRY

Friedreich Ataxia Clinical Outcome Measures

(2012) Sean R. Regner et al.   JOURNAL OF CHILD NEUROLOGY

Mortality in Friedreich Ataxia

(2011) Amy Y. Tsou et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia

(2010) Daniel Velasco-Sánchez et al.   CEREBELLUM

Clinical experience with high-dose idebenone in Friedreich ataxia

(2009) Jörg B. Schulz et al.   JOURNAL OF NEUROLOGY

Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation

(2008) O. Kakhlon et al.   BLOOD